Prellis Biologics For Profit
.jpg)
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions.
.png)
Technology:
Organ Engineering
Industry:
Regenerative medicine
Headquarters:
United States
Investors Number:
8
Total Funding:
$185M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership